Welcome to our dedicated page for Azenta SEC filings (Ticker: AZTA), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Azenta, Inc.'s SEC filings document operating results, material events, governance matters and acquisition agreements for a life sciences solutions company built around cold-chain sample management and multiomics services. Recent Form 8-K disclosures include quarterly results and financial-condition updates, leadership and board changes, and the material definitive agreement under which Azenta UK Ltd acquired UK Biocentre.
The company’s proxy and annual-meeting filings describe director elections, advisory executive-compensation votes, equity incentive plan amendments and auditor ratification. Together with material-event reports, these filings provide formal disclosure on Azenta’s governance structure, capital-related authorizations, transaction terms and recurring public-company reporting obligations.
Azenta, Inc. (AZTA) reported an equity award to one of its senior executives. On 11/24/2025, the company’s SVP and GM, Multiomics received 13,042 restricted stock units (RSUs) of Azenta common stock at a grant price of $0.00 per unit. After this grant, the executive beneficially owns 38,755 shares of Azenta common stock in total, held directly.
The filing explains that the RSU amount was calculated by dividing the target award value by the average closing price of Azenta’s common stock over the 20 trading days ending on the grant date. These RSUs are subject to time-based vesting and will vest in three equal installments of 33 1/3% per year, starting on November 24, 2026.
Azenta, Inc. (AZTA) reported an equity award to a senior executive. On November 24, 2025, the company’s SVP, General Counsel & Secretary acquired 34,235 shares of common stock through a grant of restricted stock units (RSUs) at a price of $0.00 per share. Following this grant, the executive beneficially owns 72,014 shares of Azenta common stock in direct ownership.
The RSUs were granted based on a target award value divided by the average closing price of Azenta’s common stock over the 20 trading days ending on the grant date. These RSUs are subject to time-based vesting and will vest in three equal installments of 33-1/3% per year, beginning on November 24, 2026.
Azenta, Inc. (AZTA) reported that a company director filed an amended Form 4 to correct earlier reporting of share purchases in May 2025. The director bought 100 shares on May 16, 2025 at $26.50, 4,152 shares on May 19, 2025 at $26.98, and 2,748 shares on May 20, 2025 at $27.37, all coded as open‑market purchases (code "P").
The amendment fixes administrative errors in the original filing that had understated the director’s beneficial ownership after each trade. The corrected beneficially owned share totals are 18,895 after the first purchase, 23,047 after the second, and 25,795 after the third, replacing previously miscalculated figures of 14,855, 19,007, and 21,755 shares.
Azenta, Inc. (AZTA) director filing correction: This Form 4/A amends a prior Form 4 for director William L. Cornog to fix an administrative error in his reported share ownership. After a grant of 4,040 restricted stock units on 02/04/2025, the original filing incorrectly showed 4,040 shares beneficially owned. The corrected figure is 18,795 shares of common stock underlying restricted stock units held directly. The amendment does not reflect a new transaction, only an updated and higher beneficial ownership amount for the same grant.
Azenta, Inc. (AZTA) director Martin Madaus filed an amended Form 4 to correct a prior administrative error in his reported shareholdings. The original Form 4, filed on February 11, 2025, had miscalculated the number of shares beneficially owned after a grant of 4,040 shares. The amendment clarifies that the correct number of shares beneficially owned following the transaction is 11,445 shares, not 4,040. The derivative position is reported as restricted stock units with a conversion price of $0, directly owned. This change does not reflect a new transaction but a correction to previously reported ownership.
Azenta, Inc. filed a current report announcing that it has released its financial results for the fiscal quarter and fiscal year ended September 30, 2025. The company disclosed that these results are contained in an earnings press release dated November 21, 2025, which is included as Exhibit 99.1 to the report and incorporated by reference. Azenta notes that this earnings information is being furnished under Item 2.02 of the Exchange Act and is not deemed filed for liability purposes under Section 18 or automatically incorporated into other securities law filings.
Azenta, Inc. (AZTA) executive Ginger Zhou, SVP and GM, Multiomics, reported an automatic tax-related share withholding. On 11/14/2025, 1,118 common shares were withheld at $29.75 per share to cover taxes tied to the vesting on November 15, 2025 of 4,582 restricted stock units. After this transaction, Zhou beneficially owned 25,713 Azenta common shares in direct form.
Azenta, Inc. (AZTA) senior vice president and chief human resources officer reported a Form 4 transaction involving company common stock. On 11/14/2025, 1,553 common shares were withheld at a price of $29.75 per share, coded as a tax-related transaction (Code F). This withholding covered taxes tied to the vesting on November 15, 2025 of 4,529 restricted stock units held by the insider. After this transaction, the reporting person beneficially owned 16,735 Azenta common shares, held directly.
Azenta, Inc. (AZTA) reported an insider equity transaction by its EVP, CFO and Treasurer, Lawrence Y. Lin. On 11/14/2025, 3,039 shares of common stock were withheld to cover tax obligations tied to the vesting of 10,566 restricted stock units on November 15, 2025. After this tax withholding event, the reporting person beneficially owned 42,974 shares of Azenta common stock directly. This filing reflects an administrative tax-related transaction rather than an open-market purchase or sale.
Azenta, Inc. (AZTA) president and CEO John Marotta reported a tax-related transaction involving 10,980 shares of common stock. On November 14, 2025, shares were withheld at a price of $29.75 per share to cover withholding taxes tied to the vesting of 27,872 restricted stock units on November 15, 2025. This Form 4 reflects an administrative share withholding for taxes rather than an open-market purchase or sale.